Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Net customer loans and investments up 34% year on year to over 2.2 billion euro, with SME component on the rise The result confirms the significant growth trajectory expected in profit for the year...
-
TORONTO, May 11, 2021 (GLOBE NEWSWIRE) -- Signature Resources Ltd. (TSXV: SGU, OTCQB: SGGTF, FSE 3S3) ("Signature" or the "Company") is pleased to announce it has acquired an additional 45 claims...
-
HOUSTON, May 11, 2021 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has received a notice of allowance from...
-
MINNEAPOLIS, May 11, 2021 (GLOBE NEWSWIRE) -- MissionGO, a leader in unmanned aircraft solutions that is transforming logistics; LifeSource, the organ procurement organization (OPO) serving the...
-
Strengthening the management team with deep anti-infective commercial expertise across hospital and community settings ahead of anticipated approval of Brexafemme (ibrexafungerp) in June 2021 and...
-
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- ResearchAndMarkets.compublished a new article on the petroleum industry "Oil Prices Rise Again" Oil prices moved higher after the Energy Information...
-
SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Peloton Interactive, Inc. (NASDAQ: PTON) shares. ...
-
WEST PALM BEACH, Fla., May 11, 2021 (GLOBE NEWSWIRE) -- AFC Gamma Inc. (NASDAQ:AFCG) (“AFCG” or the "Company") today announced its financial results for the fiscal quarter ended March 31, 2021. ...
-
HONG KONG, May 11, 2021 (GLOBE NEWSWIRE) -- Tailor Insight, the fintech market research organization, recently released a research report "The VR/AR was applied to the Apple conference, and WIMI...
-
Expands pipeline with new indications for PRAX-114 and PRAX-944 PRAX-114 Phase 2 trial for treatment of post-traumatic stress disorder to initiate in 2H21 PRAX-114 Phase 2 trial for...